| ||||||||||||||||||
Type Coisogenic; Mutant Strain; Transgenic; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Generation ?+N1p (12-FEB-06) Donating Investigator Katya Ravid, Boston University School of Medicine Description
Hemizygous and homozygous transgenic mice are viable, fertile, normal in size, and do not display any behavioral abnormalities. Expression of the bicistronic transgene is directed by a tetracycline-responsive regulatory element (TRE; tetO). When transgenic mice are bred with another transgenic strain expressing the tetracycline-controlled transactivator protein (tTA) under the regulation of a tissue-specific promoter, both aurora kinase B (Aurkb) and lacZ cistrons are inducibly expressed in the appropriate tissue in the bitransgenic offspring.This mouse was originally designed to be bred with Tg(Pf4-tTA)42Kra transgenic mice, which express tTA from a megakaryocyte-specific promoter. Megakaryocytes and platelet cells derived from the bitransgenic offspring show inducible and reversible beta-galactosidase expression. Further, megakaryocytes inducibly express Aurkb mRNA (but not protein) with a modest effect on megakaryocyte ploidy and no effect on platelet quantity. These double transgenic mice may be useful in studies of megakaryocyte/platelet lineage cell function, including migration following injury/insult and overexpression of thrombotic agents.
Development
A prokaryotic beta-galactosidase (lacZ) reporter gene under control of the tetracycline-response element (TRE; containing seven direct repeats of the tetracycline operator (tetO) sequence fused to a bidirectional cytomegalovirus (CMV) minimal promoter) was placed upstream of a rat Aurora-kinase B cDNA (with N-terminal FLAG-tag sequence and linked to the 3' end of the human beta-globin gene, including the 3' intron and poly A signal). The construct was injected into fertilized FVB/NJ embryos, which were then implanted into pseudopregnant foster mothers. Founder line 41 was obtained and bred to FVB/NJ mice for 3 generations. Transgenic mice were interbred for 5 generations.
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
lacZ Expression Strains
View lacZ Expression Strains (186 strains)
Strains carrying other alleles of lacZ
View Strains carrying other alleles of lacZ (43 strains)
Strains carrying other alleles of tetO
View Strains carrying other alleles of tetO (36 strains)
Fluorescent Proteins/lacZ Systems
Tet Expression Systems
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype relates to a compound genotype created using this strain.
Contact JAX® Services jaxservices@jax.org for customized breeding options.Tg(PF4-tTA/VP16)42Kra/0 Tg(tetO-Aurkb,lacZ)41Kra/0
FVB/NJ-Tg(tetO-Aurkb,lacZ)41Kra Tg(PF4-tTA/VP16)42Kra
- homeostasis/metabolism phenotype
- abnormal platelet physiology (MGI Ref ID J:104239)
- after LPS treatment, mice show accumulation of platelets in the liver and lungs in the induced (doxycycline removed) state
- hematopoietic system phenotype
- abnormal platelet physiology (MGI Ref ID J:104239)
- after LPS treatment, mice show accumulation of platelets in the liver and lungs in the induced (doxycycline removed) state
- abnormal thrombopoiesis (MGI Ref ID J:104239)
- induced mice show no increase in platelet number compared to control
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
lacZ relatedCardiovascular Research
Ischemia studies
Vascular Defects
platelet defect
Hematological Research
Clotting Defects
Platelet Defects
Research Tools
lacZ Expression
Cardiovascular Research
Tetop Tet System
Genetics Research
Mutagenesis and Transgenesis: Tetop Tet System
Hematological Research
Tet Expression Systems
tTA/rtTA Responsive Strains
Research Tools
lacZ Expression
| Allele Symbol | Tg(tetO-Aurkb,lacZ)41Kra | ||
|---|---|---|---|
| Allele Name | transgene insertion 41, Katya Ravid | ||
| Allele Type | Transgenic (Reporter) | ||
| Common Name(s) | CMV-Aurora-B/beta-gal; teto-AIM-1; | ||
| Mutation Made By | Katya Ravid, Boston University School of Medicine | ||
| Strain of Origin | FVB/NJ | ||
| Site of Expression | When crossed with a strain that expresses tTA under the regulation of a tissue-specific promoter, the transgene can be inducibly expressed in the target tissue of bitransgenic progeny. | ||
| Expressed Gene | lacZ, beta-galactosidase, E. coli | ||
| Expressed Gene | Aurkb, aurora kinase B, rat | ||
| Promoter | tetO, tet operator, | ||
| Molecular Note | A vector pBI-G (Clontech #6150-1) was used to create this transgene. The vector contains a prokaryotic beta-galactosidase (lacZ) reporter gene under control of the tetracycline-response element (TRE; containing seven direct repeats of the tetracycline operator (tetO) sequence fused to a bidirectional cytomegalovirus (CMV) minimal promoter).The rat Aurora-kinase B cDNA (with N-terminal FLAG-tag sequence and 3' linked beta-globin gene) was placed downstream of the promoter and the purified construct was injected into fertilized FVB/NJ eggs to create the transgenic mice. [MGI Ref ID J:104239] | ||
| Gene Symbol and Name | Tg(tetO-Aurkb,lacZ)41Kra, transgene insertion 41, Katya Ravid | ||
| Chromosome | UN | ||
| Gene Common Name(s) | CMV-Aurora-B/beta-gal; teto-AIM-1; | ||
Genotyping Protocols
Tg(tetO-Aurkb,lacZ)41Kra, Standard PCR
Helpful Links
Genotyping resources and troubleshooting
Nguyen HG; Yu G; Makitalo M; Yang D; Xie HX; Jones MR; Ravid K. 2005. Conditional overexpression of transgenes in megakaryocytes and platelets in vivo. Blood 106(5):1559-64. [PubMed: 15890684] [MGI Ref ID J:104239]
Currently there no information available for this strain. This may be due to the supply level of this strain.
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 Cryopreserved Embryos $1600.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 Cryopreserved Embryos $2080.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Noncarrier | ||
| 001800 FVB/NJ | ||
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.